Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 May 7;209(5):889-93.
doi: 10.1084/jem.20120741.

Prion-like spread of protein aggregates in neurodegeneration

Magdalini Polymenidou  1 , Don W Cleveland
Affiliations
Review

Prion-like spread of protein aggregates in neurodegeneration

Magdalini Polymenidou et al. J Exp Med. .

Abstract

Protein misfolding is common to most neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. Recent work using animal models with intracellular α-synuclein and tau inclusions adds decisively to a growing body of evidence that misfolded protein aggregates can induce a self-perpetuating process that leads to amplification and spreading of pathological protein assemblies. When coupled with the progressive nature of neurodegeneration, recognition of such cell-to-cell aggregate spread suggests a unifying mechanism underlying the pathogenesis of these disorders.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Scheme summarizing evidence for seeded aggregation and cell-to-cell spreading in animal models of neurodegeneration. The figure depicts the experimental paradigm originally used to replicate infectious prions in mice, which is now used to replicate spreading of misfolded Aβ, α-synuclein, and tau. Protein aggregate containing brain lysates from old sick mice (A) or pure recombinant fibrils aggregated in vitro (B) are introduced in the brains of young asymptomatic mice by injection. It is important to note that some prion-containing lysates (Chandler, 1961) or synthetic prion aggregates (Wang et al., 2010) can transmit disease to wild-type nontransgenic mice, whereas all other aggregates have thus far only been shown to induce aggregation and neuronal dysfunction in transgenic mice expressing the human versions of the respective proteins.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Aguzzi A. 2009. Cell biology: Beyond the prion principle. Nature. 459:924–925 10.1038/459924a - DOI - PubMed
    1. Aguzzi A., Polymenidou M. 2004. Mammalian prion biology: one century of evolving concepts. Cell. 116:313–327 10.1016/S0092-8674(03)01031-6 - DOI - PubMed
    1. Aguzzi A., Rajendran L. 2009. The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron. 64:783–790 10.1016/j.neuron.2009.12.016 - DOI - PubMed
    1. Aguzzi A., Sigurdson C., Heikenwaelder M. 2008. Molecular mechanisms of prion pathogenesis. Annu. Rev. Pathol. 3:11–40 10.1146/annurev.pathmechdis.3.121806.154326 - DOI - PubMed
    1. Braak H., Braak E. 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82:239–259 10.1007/BF00308809 - DOI - PubMed

Publication types

MeSH terms